The Wnt oncogene and its signaling component, beta-catenin, was confirmed by Zhang and colleagues to be significantly transcribed in lung cancer cells, and SAL was one of the compounds used to inhibit the Wingless-related integration site pathway (Wnt) signaling in their study [90]. This evidence concerns the gene CTNNB1 and lung cancer.